Association of the British Pharmaceutical Industry (ABPI)
Spending by pharma into UK R&D increases
Spending into UK research and development by the pharmaceutical industry has increased, new figures show. Read more
Science industry welcomes launch of new initiative for Northern Ireland
A new collaborative initiative has been launched to help Northern Ireland’s life sciences sector thrive. Read more
ABPI names new president to advance medicines
A new president of the Association of British Pharmaceutical Industry (ABPI) has been named to help bring new medicines to patients faster. Read more
Life sciences to have major impact on UK economy by 2025, ABPI says
Life sciences could have one of the biggest impacts on the UK economy by 2025, bringing in an additional £8.5 billion of growth, according to new research. Read more
Pharma industry responds to Brexit meaningful vote
This week (16 January) saw prime minister Theresa May’s Brexit deal firmly defeated in the House of Commons bringing forward the very real possibility of a ‘no deal’ Brexit. Read more
Brexit negotiations put patients at risk, industry says
Brexit negotiators have a duty to protect millions of patients on both sides of the Channel, a coalition from the UK’s health sector has said. Read more
Withdrawal agreement 'important step' for UK, ABPI says
The Association of the British Pharmaceutical Industry (ABPI) has responded to the Withdrawal Agreement, marking it as an "important step" towards securing a Brexit deal. Read more
Why we need a woman in science on the £50 note
Professor Carole Longson, chief scientific officer at the Association of the British Pharmaceutical Industry discusses the lack of female representation in STEM and why a woman in science is needed on the new £50 note. Read more
ABPI Chief urges rapid Brexit agreement and reveals ‘No Deal’ preparations
The chief executive of the Association of the British Pharmaceutical Industry (ABPI) will tell the House of Commons DExEU Select Committee how they are preparing for a ‘No Deal’ Brexit. Read more
Industry responds to the government’s technical notices published in case of a ‘no-deal’ Brexit
Following a speech from the secretary of state, Dominic Raab, on the steps that government as well as business and the public sector should be taking in case of a ‘no-deal’ scenario for Brexit, we take a look at some of the responses from industry… Read more
From molecule to medicine, the importance of persistence
Here, Dr Sheuli Porkess, deputy chief scientific officer, Association of the British Pharmaceutical Industry (ABPI), outlines how the pharmaceutical industry takes a substance from molecule to medicine and how the process requires persistence. Read more
The top five tweets: From OBN Awards to biologics — what did EPM readers enjoy this week?
Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. Read more
Top ten most important medicines in NHS history listed in new report
A new report from the Office of Health Economics (OHE) — commissioned by the Association of the British Pharmaceutical Industry (ABPI) — has revealed what health leaders believe to be the ten most important medicines in NHS history. Read more
ABPI responds to MHRA recent guidance on Brexit implementation
The Association of the British Pharmaceutical Industry (ABPI) has responded to the recent publication of the Medicines and Healthcare products Regulatory Agency (MHRA) technical guidance on what the Brexit implementation means for life sciences. Read more
The top five tweets: From innovation arms race to smallpox — what enlightened EPM readers this week?
Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. Read more
ABPI and BIA respond to government white paper on post-Brexit relationship with EU
A joint statement from the Association of the British Pharmaceutical Industry (ABPI) and the BioIndustry Association (BIA) has been released in response to the publication of a government white paper Read more
ABPI responds to NHS England boss’ comments on Brexit preparations
The Association of the British Pharmaceutical Industry has issued a response to comments made by Simon Stevens — chief executive of NHS England — during his interview on the Andrew Marr show earlier this month. Read more
ABPI data shows significant commitment of pharma industry to UK
Data published by the Association of the British Pharmaceutical Industry (ABPI) on Disclosure UK has revealed significant investment into R&D. Read more
The top five tweets: From industry insights to plasma manufacturing — what did EPM readers enjoy this week?
Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. Read more
Insights into the histories of the ABPI & NHS and what the future holds
Revealing her insights, Dr Sheuli Porkess, deputy chief scientific officer of the Association of the British Pharmaceutical Industry (ABPI), has recently discussed celebrating 70 years of the NHS and the ABPI, how both have been working to advance me Read more
